Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 5,676–5,700 of 27,380 studies, newest first · page 228 of 1096.

January 2025 25

  1. 2025-01-01

    Targeted demethylation of cathepsin D via epigenome editing rescues pathology in Alzheimer's disease mouse model

    ✓ Peer-reviewed Biomarkers Theranostics

    Key finding: Treatment with Ctsd-targeted dCas9-Tet1 in primary neurons overexpressing mutant APP (mutAPP) reduced Aβ peptide levels and the Aβ42/40 ratio. +2 more findings

  2. 2025-01-01

    Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial

    ✓ Peer-reviewed Biomarkers The journal of prevention of Alzheimer's disease

    Key finding: Blarcamesine, demonstrating a safety profile with no associated neuroimaging adverse events, significantly slowed clinical progression by 36.3% at 48 weeks with blarcamesine group as well as the individual 30 mg (by 34.6%) and 50 mg (by 38.5%) blarcamesine groups vs. placebo on the prespecified primary cognitive endpoint ADAS-Cog13. +4 more findings

  3. 2025-01-01
  4. 2025 no date recorded — placed by publication year

    Scaling of Small-Area Fair Market Rents: Evidence on Neighborhood Choices of Voucher Recipients

    ⚠ Preprint — not yet peer-reviewed Risk factors Not indexed

    Key finding: These results underscore the importance of accounting for implementation environments when scaling housing policy.

  5. 2025 no date recorded — placed by publication year

    The Leading Neighborhood-Level Predictors of Drug Overdose: A Mixed Machine Learning and Spatial Approach

    ⚠ Preprint — not yet peer-reviewed Risk factors Not indexed

    Key finding: Our results showed that XGBoost was the top-performing modeling approach for each domain. +4 more findings

  6. 2025 no date recorded — placed by publication year

    Neighborhood Spatial Social Polarization and Dementia Disparities Among U.S. Medicare Beneficiaries

    ✓ Peer-reviewed Risk factors Alzheimer's & Dementia

    Key finding: SSP is a flexible and predictive neighborhood‐level measure of health disparities compared to indices like the Gini coefficient. +4 more findings

  7. 2025 no date recorded — placed by publication year

    The Role of Medicare Insurance Coverage Type in Annual Wellness Visits: A Comparison between Traditional Medicare and Medicare Advantage Plan

    ✓ Peer-reviewed Health systems and care delivery Alzheimer's & Dementia

    Key finding: Enrollment in an MA plan is associated with a higher probability of AWV uptake, particularly among vulnerable populations from racial and ethnic minorities, dual eligibility, and those diagnosed with ADRD. +3 more findings

  8. 2025 no date recorded — placed by publication year

    Role of PCPs in diagnosing dementia in traditional Medicare and Medicare Advantage

    ✓ Peer-reviewed Health systems and care delivery Alzheimer's & Dementia

    Key finding: Differences in system‐level factors such as access to dementia specialists is a contributing factor to differences in diagnosis rates in MA and TM. +2 more findings

  9. 2025-01-01

    Impact of PM2.5 on Cardiovascular Disease, Dementia, and Stroke in Older Kidney Transplant Recipients

    ✓ Peer-reviewed Vascular contributions American Journal of Transplantation

    Key finding: Exposure to fine particulate matter (PM ) pollution is associated with negative health outcomes including dementia, cardiovascular disease (CVD), and stroke due to increased levels of oxidative stress and inflammation among community-dwelling older adults.

  10. 2025-01-01

    Pharmacotherapy for Poststroke Cognitive Impairment and Poststroke Cognitive Impairment With Dementia: A Review

    ✓ Peer-reviewed Vascular contributions Stroke Research and Treatment

    Key finding: Poststroke cognitive impairment (PSCI) refers to any level of cognitive decline occurring after a stroke, ranging from mild to severe impairments, while PSCI with dementia describes a more severe form where the cognitive decline significantly affects daily functioning and meets the clinical criteria for dementia. +1 more finding

  11. 2025-01-01

    Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials

    ✓ Peer-reviewed Vascular contributions Alzheimer s & Dementia Translational Research & Clinical Interventions

    Key finding: On March 12–14, 2024, the National Institute on Aging (NIA) together with the National Institute of Neurological Disorders and Stroke (NINDS) led a workshop exploring clinically meaningful changes in the context of Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) clinical trials ( https://www.nia.nih.gov/research/dbsr/workshops/clinically‐meaningful‐outcomes‐ad‐adrd‐trials ). +4 more findings

  12. 2025-01-01

    Greater White Matter Hyperintensities and More Severe Cognitive Dysfunction in Mild Cognitive Impairment With Motoric Cognitive Risk Syndrome

    ✓ Peer-reviewed Vascular contributions Journal of Korean Medical Science

    Key finding: < 0.0036), the MCRS group exhibited significantly worse performance on word list memory, word list recall, and MMSE-KC compared to the MCI group without slow gait. +1 more finding

  13. 2025-01-01

    Investigating links between white matter hyperintensities and menopausal status using robust age-correction methods in UK Biobank

    ✓ Peer-reviewed Vascular contributions Brain Communications

    Key finding: Our results pertaining to menopause-related characteristics, such as age at menopause or menopause hormonal therapy, did not replicate the literature reporting an association with WMH volumes. +4 more findings

  14. 2025-01-01
  15. 2025-01-01

    Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain study

    ✓ Peer-reviewed Vascular contributions Journal of Alzheimer s Disease Reports

    Key finding: 6.98 [2.44-19.95]; p < 0.05) driven primarily by self-identified Black race and age, while none with A and T. +3 more findings

  16. 2025-01-01

    FDG-PET anterior cingulate cortex hypometabolism as a marker of cerebral small vessel disease in Alzheimer's and vascular cognitive impairment and dementia

    ✓ Peer-reviewed Vascular contributions Cerebral Circulation - Cognition and Behavior

    Key finding: • Anterior cingulate cortex (ACC) hypometabolism is a non-specific finding in many brain disorders. • ACC hypometabolism was more common in vascular cognitive impairment and dementia (VCID) than Alzheimer dementia (AD). • ACC hypometabolism correlated with cerebral small vessel disease markers. • ACC hypometabolism may be associated with motor stereotypies in VCID. • FDG-PET patterns of hypometabolism may identify vascular contributions to cognitive impairment The anterior cingulate cortex (ACC) is an important hub in the executive and salience networks. +1 more finding

  17. 2025-01-01

    Endothelial progenitor cells and cerebral small vessel disease in APOE4 carriers

    ✓ Peer-reviewed Vascular contributions Cerebral Circulation - Cognition and Behavior

    Key finding: • APOE4 carriers exhibit cerebrovascular dysfunction. • Endothelial progenitor cells (EPC) represent cell populations involved in facilitating vascular repair. • In APOE4 carriers, EPC colony count is associated with cerebral small vessel disease. • EPC colony count may indicate activation of mechanisms which protect cerebrovascular function in APOE4 carriers prior to the development of cognitive decline. +3 more findings

  18. 2025-01-01

    Perivascular spaces, diffusion MRI markers and cognitive decline in cerebral small vessel disease

    ✓ Peer-reviewed Vascular contributions Cerebral Circulation - Cognition and Behavior

    Key finding: Cohort 1 included 446 individuals (mean age (SD) 65.2 years (8.9); 203 women), Cohort 2 included 164 individuals (mean age (SD) 49.9 years (12.6); 88 women). +4 more findings

  19. 2025-01-01

    Cerebral Small Vessel Disease: Current and Emerging Therapeutic Strategies

    ✓ Peer-reviewed Vascular contributions Aging and Disease

    Key finding: Cerebral small vessel disease (CSVD) is a common disease in older people, characterized by damage to intracranial microvessels, leading to cognitive decline, increased risk of stroke, and dementia.

  20. 2025-01-01

    The Aging Population and Dementia: The Need for Comprehensive Palliative Care

    ✓ Peer-reviewed End-of-life care Acta medica Indonesiana

    Key finding: This disease not only impacts the individual but also has significant consequences for their families and caregivers.

  21. 2025-01-01

    Dementia in palliative care

    ✓ Peer-reviewed End-of-life care Medycyna Paliatywna

    Key finding: Otępienie to zespół objawów wywołany postępującymi chorobami neurodegeneracyjnymi mózgu, które prowadzą do znacznego pogorszenia funkcji poznawczych, a w końcowym etapie do całkowitej zależności pacjenta od otoczenia. +1 more finding

  22. 2025-01-01

    Shaping a knowable event or embracing a mysterious journey: A mixed methods study on palliative care clinician views on voluntary assisted dying

    ✓ Peer-reviewed End-of-life care Palliative & Supportive Care

    Key finding: Of 142 respondents, 53% supported, 10% were uncertain, and 37% opposed legalizing euthanasia for terminal illness with severe symptoms. +4 more findings

  23. 2025-01-01

    Assessment of end-of-life care needs among patients with incurable diseases in Bangladesh: A multicenter study

    ✓ Peer-reviewed End-of-life care Palliative & Supportive Care

    Key finding: All patients had a Needs Near the End-of-Life Care Screening (NEST-13) score ≥30, indicating a high level of EOL care need. +3 more findings

  24. 2025-01-01

    Suffering and loss in Lewy body dementia: Applying a palliative care lens to a longitudinal narrative study

    ✓ Peer-reviewed End-of-life care Palliative & Supportive Care

    Key finding: Participants with Lewy body dementia described losses associated with communication, continence, and energy leading to a progressive loss of independence. +4 more findings

  25. 2025-01-01

    Exploring advance care planning discourses in scottish dementia policies: A critical discourse analysis

    ✓ Peer-reviewed End-of-life care Social Sciences & Humanities Open

    Key finding: The analysis revealed that dementia policies inadequately supported the initiation and revision of ACPs for PwD. +1 more finding

Browse the library by subject, with the full score breakdown →